A detailed history of Advisor Group Holdings, Inc. transactions in Profound Medical Corp. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 646 shares of PROF stock, worth $4,877. This represents 0.0% of its overall portfolio holdings.

Number of Shares
646
Previous 646 -0.0%
Holding current value
$4,877
Previous $5,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$7.25 - $9.07 $906 - $1,133
-125 Reduced 16.21%
646 $5,000
Q1 2024

May 10, 2024

SELL
$7.3 - $9.46 $2,190 - $2,838
-300 Reduced 28.01%
771 $6,000
Q2 2023

Aug 10, 2023

BUY
$9.27 - $14.88 $3,439 - $5,520
371 Added 53.0%
1,071 $13,000
Q3 2021

Nov 05, 2021

BUY
$13.6 - $17.88 $6,800 - $8,940
500 Added 250.0%
700 $10,000
Q3 2020

Nov 12, 2020

SELL
$14.05 - $18.13 $10,678 - $13,778
-760 Reduced 79.17%
200 $4,000
Q1 2020

May 18, 2020

BUY
$6.88 - $19.7 $6,604 - $18,912
960 New
960 $9,000

Others Institutions Holding PROF

About Profound Medical Corp.


  • Ticker PROF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 20,851,300
  • Market Cap $157M
  • Description
  • Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...
More about PROF
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.